Complete Peptide Dosing
& Reconstitution Guide
Clinical dosing reference with reconstitution protocols, vial sizing, and administration guidance for all Matrix-supported compounds.
Edition: March 2026 | Version 2.0
For clinical-support and educational purposes only. All protocols must be supervised by a licensed prescriber. Matrix Advanced Solutions does not provide medical advice.
Table of Contents
Quick-jump to any compound, stack, or reference section
Immune & Anti-Inflammatory
How to Reconstitute Your Peptide
Everything you need to know before your first injection
What You Need
Peptide Vial
Lyophilized (freeze-dried) powder from Matrix
Bacteriostatic Water (BAC)
Sterile water with 0.9% benzyl alcohol preservative
Insulin Syringes
1 mL (100 unit) with 29–31 gauge needle
Alcohol Swabs
70% isopropyl for vial tops and injection site
Why Bacteriostatic Water?
BAC water contains a preservative (benzyl alcohol) that prevents bacterial growth, allowing your reconstituted peptide to last 30–90 days refrigerated. Never use plain sterile water — it has no preservative and must be used within 24 hours.
Step-by-Step Reconstitution
- Wash your hands thoroughly. Work on a clean surface. Have all supplies ready.
- Swab both vial tops — the peptide vial and the BAC water vial — with alcohol. Let dry for 10 seconds.
- Draw BAC water into the syringe. Pull back the plunger slowly to the desired volume (see reconstitution math below).
- Insert the needle into the peptide vial at an angle. Aim the stream at the glass wall — never squirt directly onto the powder. Let the water trickle down the side gently.
- Do NOT shake. Gently swirl or roll the vial between your palms until fully dissolved. The solution should be clear — if cloudy, continue gently swirling.
- Label the vial with: compound name, reconstitution date, concentration (mcg per unit), and your initials.
- Store refrigerated (36–46°F / 2–8°C). Good for 30–90 days. Never freeze reconstituted peptide.
Critical
Never shake the vial — peptides are fragile proteins. Aggressive agitation denatures the compound and destroys its bioactivity. Gentle swirling only.
Visual Reconstitution Guide
Follow these 5 steps every time you reconstitute a new vial. Each step includes an animated illustration.
Key Reminders
Aim at the glass wall when adding water — never squirt onto the powder. Gently roll between palms — never shake. Label your vial with compound name, date, and concentration (mcg/unit).
Video Tutorial
Watch the full reconstitution walkthrough:
Click to play — covers supplies, mixing technique, dosing math, and injection.
Reconstitution Math
Every reconstituted vial has a concentration — how many micrograms (mcg) are in each unit on your insulin syringe. The math is simple:
Quick Reference Examples
BPC-157 • 5 mg vial
Add 2 mL BAC water (200 units)
5,000 mcg ÷ 200 units
= 25 mcg per unit
250 mcg dose = 10 units
Ipamorelin • 5 mg vial
Add 2 mL BAC water (200 units)
5,000 mcg ÷ 200 units
= 25 mcg per unit
200 mcg dose = 8 units
Semaglutide • 5 mg vial
Add 2 mL BAC water (200 units)
5,000 mcg ÷ 200 units
= 25 mcg per unit
250 mcg dose = 10 units
GHK-Cu • 50 mg vial
Add 5 mL BAC water (500 units)
50,000 mcg ÷ 500 units
= 100 mcg per unit
2 mg dose = 20 units
Simple Rule of Thumb
Adding 2 mL of BAC water to a 5 mg vial always gives you 25 mcg per unit. This is the most common setup and makes dosing math easy. For a 10 mg vial with 2 mL, you get 50 mcg per unit.
How to Inject (Subcutaneous)
- Swab the vial top with alcohol. Draw your calculated dose by pulling the plunger to the correct unit mark.
- Choose an injection site: lower abdomen (2 inches from navel), upper thigh, or back of upper arm. Rotate sites daily.
- Swab the injection site with alcohol. Let dry completely.
- Pinch a fold of skin and insert the needle at a 45–90° angle. Push the plunger steadily — don't rush.
- Hold for 5 seconds after fully depressed, then withdraw. Gentle pressure with alcohol swab if needed. Don't rub.
Timing Matters
Most GH peptides (Ipamorelin, CJC-1295, GHRP-6, Sermorelin) should be taken on an empty stomach — at least 30 minutes before eating or 2 hours after. Food (especially fats and carbs) blunts the GH pulse. Metabolic peptides (Semaglutide, Tirzepatide, Retatrutide) can be taken any time — once weekly.
Storage Quick Reference
| State | Storage | Duration |
| Unreconstituted (powder) | Refrigerator or room temp (cool, dark) | 12–24 months |
| Reconstituted (in BAC water) | Refrigerator only (36–46°F / 2–8°C) | 30–90 days max |
| Reconstituted (in sterile water) | Refrigerator only | Use within 24 hours |
#09
Retatrutide
Triple Agonist — GLP-1 / GIP / Glucagon Receptor
GLP-1 / Metabolic
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 2 mg = |
| 5 mg | 2 mL | 25 mcg/unit | 80 units |
| 10 mg | 2 mL | 50 mcg/unit | 40 units |
| 20 mg | 2 mL | 100 mcg/unit | 20 units |
| 60 mg | 3 mL | 200 mcg/unit | 10 units |
Dosing Protocol
| Parameter | Details |
|---|
| Start | 1 mg weekly x4 weeks |
| Titrate | 2 mg → 4 mg → 8 mg → 12 mg (monthly steps) |
| Maintenance | 8–12 mg weekly |
| Route | SubQ once weekly |
Key Benefits
Significant weight lossTriple receptor actionGlycemic controlAppetite suppression
Confidence: HighSources: Retatrutide.pdf
#10
Semaglutide
GLP-1 Receptor Agonist — Industry-Leading Weight Management
GLP-1 / Metabolic
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 0.25 mg = |
| 5 mg | 2 mL | 25 mcg/unit | 10 units |
| 10 mg | 2 mL | 50 mcg/unit | 5 units |
| 20 mg | 2 mL | 100 mcg/unit | 2.5 units |
| 60 mg | 3 mL | 200 mcg/unit | 1.25 units |
Dosing Protocol
| Parameter | Details |
|---|
| Start | 0.25 mg weekly x4 weeks |
| Titrate | 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg (monthly) |
| Maintenance | 1.7–2.4 mg weekly |
| Route | SubQ once weekly |
Key Benefits
15–17% weight lossCV benefitGlycemic controlOnce-weekly
Confidence: LowSources: Matrix seed list (no source PDF)
#11
Tirzepatide
Dual GLP-1 / GIP Agonist — Enhanced Metabolic Control
GLP-1 / Metabolic
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 2.5 mg = |
| 5 mg | 2 mL | 25 mcg/unit | 100 units |
| 10 mg | 2 mL | 50 mcg/unit | 50 units |
| 20 mg | 2 mL | 100 mcg/unit | 25 units |
| 60 mg | 3 mL | 200 mcg/unit | 12.5 units |
Dosing Protocol
| Parameter | Details |
|---|
| Start | 2.5 mg weekly x4 weeks |
| Titrate | 5 → 7.5 → 10 → 12.5 → 15 mg |
| Maintenance | 10–15 mg weekly |
| Route | SubQ once weekly |
Key Benefits
Up to 22% weight lossDual agonistA1c reductionGood tolerability
Confidence: LowSources: Matrix seed list (no source PDF)
Tissue Repair & Recovery
Systemic and localized repair peptides for injury, gut healing, and tissue remodeling
#01
BPC-157
Body Protection Compound-157 — Pentadecapeptide
Tissue Repair
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 250 mcg = |
| 5 mg | 2 mL | 25 mcg/unit | 10 units |
| 10 mg | 2 mL | 50 mcg/unit | 5 units |
Mechanism
Upregulates VEGF, FGF, EGF growth factors. Promotes angiogenesis, accelerates tendon-to-bone healing, and stabilizes gut mucosal tight junctions via nitric oxide modulation.
Dosing Protocol
| Parameter | Details |
| Systemic Dose | 250–500 mcg 1–2x daily |
| Local Injection | 250–500 mcg near injury site |
| Oral (Gut) | 250–500 mcg daily on empty stomach |
| Route | SubQ, IM (local), or Oral |
| Cycle | 4–6 weeks, repeat after 2-week break |
Key Benefits
Tendon & ligament repairGut mucosa healingMuscle recoveryAnti-inflammatoryNeuroprotective
Safety
- Excellent safety profile — no significant adverse events
- Mild injection site irritation possible
- Avoid in active malignancy (theoretical growth factor concern)
Confidence: HighSources: BPC-157.pdf, M05, M06, M08
#02
TB-500
Thymosin Beta-4 Fragment — Systemic Repair Peptide
Tissue Repair
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 750 mcg = |
| 5 mg | 2 mL | 25 mcg/unit | 30 units |
| 10 mg | 2 mL | 50 mcg/unit | 15 units |
Dosing Protocol
| Parameter | Details |
| Loading Phase | 750 mcg – 2 mg 2x/week for 4–6 weeks |
| Maintenance | 750 mcg – 2 mg 1x/week or biweekly |
| Route | Subcutaneous injection |
| Cycle | 4–6 weeks loading, then maintenance |
Key Benefits
Systemic tissue repairReduced inflammationImproved flexibilityHair regrowth supportCardiac tissue repair
Confidence: HighSources: TB-500.pdf, M06, M08
#03
GHK-Cu
Copper Tripeptide — Collagen Remodeling & Anti-Aging Signal Peptide
Skin / Collagen
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 2 mg = |
| 50 mg | 5 mL | 100 mcg/unit | 20 units |
| 100 mg | 5 mL | 200 mcg/unit | 10 units |
Dosing Protocol
| Parameter | Details |
| SubQ Dose | 1–2 mg daily or every other day |
| Topical | Apply to target area 1–2x daily |
| Route | SubQ or topical cream/serum |
| Cycle | 8–12 weeks, repeatable |
Important — Separate Vial Required
GHK-Cu must be kept separate from other peptides. Copper degrades other compounds. Use a dedicated vial and syringe — never mix with BPC-157 or TB-500 in the same solution.
Key Benefits
Collagen synthesisSkin rejuvenationWound healingAnti-aging gene regulationHair follicle support
Confidence: HighSources: GHK-Cu.pdf, M06, M08
Skin, Hair & Aesthetics
Melanogenesis, hair preservation, and dermal support compounds
#21
MT-2 (Melanotan II)
Alpha-MSH Analog — Melanogenesis Activator
Tanning / Libido
Dosing Protocol
| Parameter | Details |
|---|
| Loading | 250–500 mcg daily until desired tan |
| Maintenance | 250–500 mcg 1–2x/week |
| Route | SubQ |
| Note | UV exposure within 2–4 hrs enhances effect |
Safety
- Nausea common — start low
- Mole darkening — monitor carefully
- Avoid in melanoma history
Confidence: HighSources: MT-2.pdf
Topical
Solution
#30
Follic RX
Compounded 4-in-1 Topical — Multi-Mechanism Hair Treatment
Hair Loss
No Reconstitution — Topical
Key Benefits
Multi-mechanismLocal DHT blockadeVasodilationLow systemic exposure
Confidence: HighSources: Follic RX.pdf
Topical
Solution
#31
RU-58841
Topical Anti-Androgen — Research Chemical DHT Blocker
Hair Loss
Research Chemical
No FDA approval. No long-term safety data. Monitor for systemic anti-androgenic effects.
Confidence: HighSources: RU-58841.pdf

Energy & Longevity
Cellular energy, telomere maintenance, and healthy aging
#14
MOTS-c
Mitochondrial-Derived Peptide — AMPK Activator
Mitochondrial
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 5 mg = |
| 10 mg | 2 mL | 50 mcg/unit | 100 units |
| 20 mg | 2 mL | 100 mcg/unit | 50 units |
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 5–10 mg 3–5x per week |
| Route | Subcutaneous injection |
| Cycle | 4–8 weeks |
Key Benefits
AMPK activationMetabolic optimizationExercise mimeticInsulin sensitivity
Confidence: HighSources: MOTS-c.pdf, M06
#15
Epitalon
Epithalon — Telomerase Activator & Pineal Peptide
Longevity
Reconstitution Guide
Concentration
100 mcg/unit
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 5–10 mg daily for 10–20 days |
| Route | Subcutaneous injection |
| Cycle | 10–20 day course, 2–3x per year |
Key Benefits
Telomerase activationMelatonin regulationAnti-agingSleep quality
Confidence: HighSources: Epitalon.pdf, M06
#16
NAD+
Nicotinamide Adenine Dinucleotide — Essential Cellular Coenzyme
Cellular Energy
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 100 mg = |
| 500 mg | 5 mL | 1,000 mcg/unit | 100 units |
| 1,000 mg | 5 mL | 2,000 mcg/unit | 50 units |
Dosing Protocol
| Parameter | Details |
|---|
| IV Protocol | 250–500 mg IV infusion (2–4 hrs) |
| SubQ Protocol | 100–200 mg daily or every other day |
| Maintenance | IV monthly + SubQ between |
Key Benefits
Cellular energyDNA repairSirtuin activationNeuroprotection
Confidence: HighSources: NAD.pdf, M06

Cognition & Neuro
Intranasal neuropeptides for cognitive enhancement and anxiolysis
#12
Semax
Synthetic ACTH(4-10) Analog — Intranasal BDNF Booster
Cognition
Nasal Spray — Available Sizes
| Size | Route | Standard Dose |
| 10 mg | Intranasal | 200–600 mcg/day |
| 20 mg | Intranasal | 200–600 mcg/day |
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 200–600 mcg daily (intranasal) |
| NA-Semax Amidate | 100–300 mcg daily (enhanced variant) |
| Timing | Morning — 1–2 sprays per nostril |
| Cycle | 2–4 weeks on, 1–2 weeks off |
Key Benefits
BDNF upregulationCognitive enhancementNeuroprotectionFocus & memory
Confidence: HighSources: Semax.pdf, M06, M08
#13
Selank
Synthetic Tuftsin Analog — Anxiolytic GABA Modulator
Anxiolytic
Nasal Spray — Pre-Mixed
Standard Dose
250–500 mcg/day
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 250–500 mcg daily |
| Timing | Morning or as needed for anxiolysis |
| Cycle | 2–4 weeks on, 1–2 weeks off |
Key Benefits
Anxiolytic without sedationGABA modulationStress resilienceCalm focus
Confidence: HighSources: Selank.pdf, M06, M08
Growth Hormone Axis
GH secretagogues and GHRH analogs for pulsatile growth hormone optimization
#04
Ipamorelin
Selective GH Secretagogue — Clean Pituitary GH Pulse
GH Secretagogue
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 200 mcg = |
| 5 mg | 2 mL | 25 mcg/unit | 8 units |
| 10 mg | 2 mL | 50 mcg/unit | 4 units |
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 200–300 mcg 2–3x daily |
| Route | Subcutaneous injection |
| Timing | Fasted — AM, post-workout, and/or before bed |
| Cycle | 8–12 weeks on, 4 weeks off |
Key Benefits
Clean GH elevationImproved sleepFat loss supportRecoveryAnti-aging
Confidence: HighSources: Ipamorelin.pdf, M05, M06, M08
#05
CJC-1295
GHRH Analog — DAC (Long-Acting) & No-DAC (Mod GRF 1-29)
GHRH Analog
Reconstitution Guide — No-DAC
Dosing Protocol
| Parameter | Details |
|---|
| No-DAC (Mod GRF) | 100 mcg 2–3x daily (pair with Ipamorelin) |
| With DAC | 2 mg 1–2x per week |
| Route | Subcutaneous injection |
| Timing | Fasted for no-DAC; any time for DAC |
| Cycle | 8–12 weeks on, 4 weeks off |
Key Benefits
Sustained GH elevationSynergy with GHRPsBody compositionDeep sleep
Confidence: HighSources: CJC-1295.pdf, M06, M08
#06
Tesamorelin
FDA-Approved GHRH Analog — Visceral Fat Reduction
GHRH Analog
Reconstitution Guide — All Vial Sizes
| Vial | BAC Water | Concentration | 2 mg = |
| 5 mg | 2.5 mL | 20 mcg/unit | 100 units |
| 10 mg | 2 mL | 50 mcg/unit | 40 units |
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 2 mg daily |
| Route | Subcutaneous injection (abdomen) |
| Timing | Evening or before bed, fasted |
| Cycle | 12–26 weeks (FDA-studied durations) |
Key Benefits
Visceral fat reductionFDA-approvedIGF-1 elevationCognitive support
Confidence: HighSources: Tesamorelin.pdf, M06
#07
MK-677 (Ibutamoren)
Oral Ghrelin Mimetic — Non-Peptide GH Secretagogue
GH Secretagogue
No Reconstitution Needed — Oral Capsule
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 10–25 mg daily |
| Timing | Before bed (minimizes daytime hunger) |
| Cycle | 8–12 weeks, or continuous with monitoring |
Safety
- Increased appetite and water retention common
- May raise fasting blood glucose — monitor in pre-diabetics
- Transient lethargy in first weeks
Confidence: HighSources: MK-677.pdf, M06
#08
Sermorelin
GHRH (1-29) — Classic Growth Hormone Releasing Hormone
GHRH Analog
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 200–500 mcg daily |
| Route | Subcutaneous injection |
| Timing | Before bed, fasted |
| Cycle | 3–6 months for full benefit |
Key Benefits
Conservative GH boostStrong safety recordSleep qualityAnti-aging
Confidence: ModerateSources: SEM_GHK Stack.pdf, M06
#37
GHRP-6
Growth Hormone Releasing Peptide-6 — Ghrelin-Mimetic Secretagogue
GH Secretagogue
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 100–300 mcg per injection, 2–3x daily |
| Route | Subcutaneous injection |
| Timing | Fasted — 30 min before meals or 2 hrs after |
| Cycle | 8–12 weeks on, 4 weeks off |
Appetite Warning
Significant appetite increase — not ideal for caloric restriction. Ipamorelin preferred for most clients. GHRP-6 reserved for underweight or recovery-focused protocols.
Confidence: ModerateSources: M06 (Academy only) — REVIEW REQUIRED

Sleep Support
Neuromodulatory peptides for sleep architecture and circadian regulation
#17
DSIP
Delta Sleep-Inducing Peptide — Deep Sleep Architecture Support
Sleep
Dosing Protocol
| Parameter | Details |
|---|
| Standard Dose | 100–200 mcg before bed |
| Route | SubQ or intranasal |
| Timing | 30–60 min before sleep |
| Cycle | 2–4 weeks, as needed |
Key Benefits
Delta wave sleepCircadian resetStress bufferingNon-habit forming
Confidence: HighSources: DSIP.pdf

Immune & Anti-Inflammatory
Immune modulators, antimicrobials, and anti-inflammatory peptides
#18
Thymosin Alpha-1
TA1 — T-Cell Modulator & Immune Enhancer
Immune
Dosing Protocol
| Parameter | Details |
|---|
| Standard | 1.6 mg 2x per week |
| Acute/Loading | 1.6 mg daily for 5–7 days |
| Route | Subcutaneous injection |
| Cycle | 4–8 weeks or ongoing |
Key Benefits
T-cell enhancementNK cell activityVaccine adjuvantChronic infection
Confidence: HighSources: TA1.pdf, M06
#19
KPV
Lys-Pro-Val — Alpha-MSH-Derived Anti-Inflammatory Tripeptide
Anti-Inflammatory
Dosing Protocol
| Parameter | Details |
|---|
| Starting | 250 mcg daily |
| Standard | 500 mcg daily |
| High | 1,000 mcg daily |
| Route | SubQ or oral capsule |
| Cycle | 4–8 weeks |
Key Benefits
Gut mucosa healingTNF-alpha suppressionIBD/IBS reliefNF-kB inhibition
Confidence: ModerateSources: KLOW Stack.pdf, M06
#20
Glutathione
L-Glutathione — Master Antioxidant & Detoxification Agent
Antioxidant
Multiple Routes Available
Key Benefits
Master antioxidantLiver detoxImmune defenseSkin brightening
Confidence: HighSources: Glutathione.pdf
#38
LL-37
Human Cathelicidin — Broad-Spectrum Antimicrobial Peptide
Antimicrobial
Dosing Protocol
| Parameter | Details |
|---|
| Starting | 50 mcg daily |
| Standard | 100 mcg daily |
| Acute | 100–200 mcg daily (short-term) |
| Route | Subcutaneous injection |
| Cycle | 4–6 weeks |
Review Required
Academy-sourced only. Start low — Herxheimer-like reactions possible. Combine with Glutathione for detox support.
Confidence: LowSources: M06 — FULL REVIEW REQUIRED

Growth Factors
Advanced growth factors for targeted muscle repair and hypertrophy
#22
IGF-1 (LR3 & DES)
Insulin-Like Growth Factor 1 — Two Variants
Growth Factor
Reconstitution Guide — LR3
Dosing Protocol
| Parameter | Details |
|---|
| IGF-1 LR3 | 20–50 mcg daily (systemic) |
| IGF-1 DES | 50–100 mcg pre-workout (localized) |
| Route | SubQ (LR3) or IM at target (DES) |
| Cycle | 4–6 weeks |
Hypoglycemia Risk
Always have glucose available. Advanced compound — practitioner oversight essential. Avoid in active malignancy.
Confidence: HighSources: IGF-1.pdf
#23
PEG-MGF
Pegylated Mechano Growth Factor — Satellite Cell Activator
Muscle Repair
Dosing Protocol
| Parameter | Details |
|---|
| Standard | 200 mcg per injection site |
| Frequency | 2–3x per week |
| Route | IM at target muscle |
| Cycle | 4–6 weeks |
Confidence: ModerateSources: PEG-MGF.pdf

Hormone Support & PCT
Testosterone support, post-cycle therapy, and estrogen management
#24
HCG
Human Chorionic Gonadotropin — Testicular Function Support
Hormone / PCT
Dosing Protocol
| Parameter | Details |
|---|
| On-TRT | 500 IU 2–3x/week |
| PCT | 1,000–1,500 IU EOD for 2–3 weeks |
| Fertility | 500–1,000 IU 3x/week |
| Route | SubQ or IM |
Confidence: HighSources: HCG.pdf
Oral
Compound
No Vial
#25
Enclomiphene
SERM — Natural Testosterone Stimulation
Hormone / PCT
No Reconstitution Needed — Oral
Key Benefits
Natural T boostPreserves fertilityNo suppression
Confidence: HighSources: Enclomiphene.pdf
Oral
Compound
No Vial
#26
Exemestane
Aromasin — Suicidal Aromatase Inhibitor
Estrogen Mgmt
No Reconstitution Needed — Oral
Lab Monitoring Required
Monitor E2 regularly — do not crash estrogen. Take with fat for absorption.
Confidence: HighSources: Exemestane.pdf

Cardiovascular Support
Blood pressure, heart rate, and lipid management
Oral
Medication
#27
Telmisartan
ARB with PPAR-gamma — Blood Pressure & Metabolic Support
Cardiovascular
No Reconstitution — Oral Tablet
Key Benefits
BP reductionPPAR-gammaOrgan protectionLongest half-life ARB
Confidence: HighSources: Telmisartan.pdf
Oral
Medication
#28
Nebivolol
Vasodilating Beta-Blocker — Beta-1 Selective + NO
Cardiovascular
No Reconstitution — Oral Tablet
Key Benefits
Heart rate controlNO vasodilationMinimal metabolic effects
Confidence: HighSources: Nebivolol.pdf
Oral
Medication
#29
Ezetimibe
NPC1L1 Inhibitor — Cholesterol Absorption Blocker
Cholesterol
No Reconstitution — Oral Tablet
Key Benefits
15–20% LDL cutStatin adjunctSimple dosing
Confidence: HighSources: Ezetimibe.pdf
Not Recommended
Not
Recommended
#32
5-Amino-1-MQ
NNMT Inhibitor — Disputed
Reported Dosing
| Parameter | Details |
|---|
| Reported | 50–100 mg daily oral |
Source Advisory
Source explicitly says waste of money. Limited evidence. Not recommended for Matrix protocols.
Confidence: High (in non-recommendation)
Not Recommended
Not
Recommended
#33
HGH Frag 176-191
Growth Hormone Fragment — Disputed
Reported Dosing
| Parameter | Details |
|---|
| Reported | 250–500 mcg 2x daily SubQ |
Source Advisory
Source explicitly says waste of money. Better GH-axis options exist.
Confidence: High (in non-recommendation)

SARMs — Discouraged
Source material advises against all SARM use. Harm reduction reference only.
Discouraged
Oral
Discouraged
#34
RAD-140 (Testolone)
SARM — Hepatotoxicity & Suppression Risk
| Reported | Details |
|---|
| Dose | 10–20 mg daily oral, 6–8 wks + PCT |
Discouraged
Hepatotoxicity, hormonal suppression, no FDA approval, unknown long-term effects.
Discouraged
Oral
Discouraged
#35
LGD-4033 (Ligandrol)
SARM — Significant Suppression Risk
| Reported | Details |
|---|
| Dose | 5–10 mg daily oral, 6–8 wks + PCT |
Discouraged
Significant testosterone suppression, hepatic strain, no regulatory approval.
Discouraged
Oral
Discouraged
#36
Ostarine (MK-2866)
Enobosarm — "Mild" SARM Still Causes Suppression
| Reported | Details |
|---|
| Dose | 10–25 mg daily oral, 6–8 wks + PCT |
Discouraged
Often marketed as "mild" but still causes hormonal suppression. No long-term safety data.

Stack Protocols
Pre-validated multi-compound protocols for synergistic clinical outcomes
S1: BPC-157 + TB-500
BPC-157 • TB-500
Protocol
Foundational tissue repair. BPC-157 targets local repair via growth factor upregulation; TB-500 provides systemic anti-inflammatory support.
| Component | Dose | Frequency |
|---|
| BPC-157 | 250–500 mcg | 1–2x daily (SubQ) |
| TB-500 | 750 mcg – 2 mg | 2x/week loading → 1x/week |
Confidence: HighSources: BPC+TB500.pdf
S2: GLOW Stack
BPC-157 • TB-500 • GHK-Cu
Protocol
Repair + rejuvenation. Adds GHK-Cu collagen signaling to the BPC/TB foundation. GHK-Cu must be in a separate vial.
| Component | Dose | Frequency |
|---|
| BPC-157 | 250–500 mcg | 1–2x daily |
| TB-500 | 750 mcg – 2 mg | 2x/week |
| GHK-Cu | 1–2 mg | Daily (separate vial) |
Confidence: HighSources: GLOW Stack.pdf
S3: KLOW Stack
BPC-157 • TB-500 • GHK-Cu • KPV
Protocol
Complete gut-healing + tissue-rebuilding. Adds KPV anti-inflammatory action for IBD/IBS support and systemic inflammation.
| Component | Dose | Frequency |
|---|
| BPC-157 | 250–500 mcg | 1–2x daily |
| TB-500 | 750 mcg – 2 mg | 2x/week |
| GHK-Cu | 1–2 mg | Daily (separate vial) |
| KPV | 250–500 mcg | Daily |
Confidence: HighSources: KLOW Stack.pdf
S4: MOTS-c + Semax
MOTS-c • Semax
Protocol
Mitochondrial energy + cognitive enhancement. MOTS-c AMPK activation paired with Semax BDNF neuroprotection.
| Component | Dose | Frequency |
|---|
| MOTS-c | 5–10 mg | 3–5x/week (SubQ) |
| Semax | 200–600 mcg | Daily (intranasal) |
Confidence: HighSources: MOTS-c+Semax.pdf
S5: Retatrutide + Tesamorelin
Retatrutide • Tesamorelin
Protocol
Dual metabolic powerhouse. Triple-agonist GLP-1 paired with GHRH analog for comprehensive body composition management.
| Component | Dose | Frequency |
|---|
| Retatrutide | 1 mg → up to 12 mg | Once weekly (SubQ) |
| Tesamorelin | 2 mg | Daily (SubQ, evening) |
Confidence: HighSources: Reta+Tesa.pdf
S6: SEM/GHK Stack
Sermorelin • GHK-Cu
Protocol
GH axis + collagen remodeling. Sermorelin GHRH stimulation paired with GHK-Cu copper peptide for anti-aging and skin quality.
| Component | Dose | Frequency |
|---|
| Sermorelin | 200–500 mcg | Daily before bed (SubQ) |
| GHK-Cu | 1–2 mg | Daily (separate vial) |
Confidence: HighSources: SEM_GHK.pdf
Appendix: Abbreviations
| Term | Meaning |
| BAC Water | Bacteriostatic water (0.9% benzyl alcohol) |
| SubQ | Subcutaneous injection |
| IM | Intramuscular injection |
| IV | Intravenous infusion |
| EOD | Every other day |
| PCT | Post-cycle therapy |
| GH | Growth hormone |
| GHRH | Growth hormone releasing hormone |
| GHRP | Growth hormone releasing peptide |
| GLP-1 | Glucagon-like peptide-1 |
| BDNF | Brain-derived neurotrophic factor |
| AMPK | AMP-activated protein kinase |
| TRT | Testosterone replacement therapy |
| SERM | Selective estrogen receptor modulator |
| ARB | Angiotensin receptor blocker |
| Unit | 1/100th of 1 mL on an insulin syringe |
Matrix Advanced Solutions
This catalog is for clinical-support and educational purposes only. All dosing protocols must be supervised by a licensed prescriber. Matrix Advanced Solutions does not provide medical advice.
Always consult your healthcare provider before starting any peptide or compound protocol. Dosing ranges represent general guidance and must be individualized based on patient history, labs, and clinical judgment.
Complete Peptide Dosing & Reconstitution Catalog — March 2026, v2.0 — © Matrix Advanced Solutions